Copyright
©The Author(s) 2016.
World J Gastroenterol. Jul 21, 2016; 22(27): 6224-6234
Published online Jul 21, 2016. doi: 10.3748/wjg.v22.i27.6224
Published online Jul 21, 2016. doi: 10.3748/wjg.v22.i27.6224
Hepatitis B-associated HCC(n = 30) | Hepatitis C-associated HCC(n = 38) | P value | |
Sex (M/F) | 28/2 | 22/16 | < 0.011 |
Age (yr) | 62.6 ± 10.9 | 73.4 ± 9.7 | < 0.012 |
Albumin (g/dL) | 3.4 ± 0.6 | 3.4 ± 0.5 | NS2 |
Total bilirubin (mg/dL) | 1.2 ± 0.6 | 1.4 ± 1.3 | NS2 |
AST (U/L) | 75.6 ± 76.2 | 57.8 ± 31.6 | NS2 |
ALT (U/L) | 54.3 ± 38.4 | 49.8 ± 38.3 | NS2 |
Fasting blood glucose (mg/dL) | 104.5 ± 22.2 | 113.1 ± 36.0 | NS2 |
γ-glutamyl transferase (U/L) | 77.0 ± 64.8 | 60.4 ± 58.1 | NS2 |
Creatinine (mg/dL) | 0.73 ± 0.19 | 1.01 ± 1.53 | NS2 |
Platelet count (× 103/μL) | 13.5 ± 8.4 | 11.7 ± 4.7 | NS2 |
Fib-4 index | 5.7 ± 4.4 | 6.4 ± 3.9 | NS2 |
AFP (ng/mL) ≤ 6.2 /> 6.2 | 10/20 | 8/30 | NS1 |
DCP (mAU/mL) ≤ 40 /> 40 | 17/13 | 24/14 | NS1 |
HBs antigen, positive | 30 | 0 | |
HCV-antibody, positive | 0 | 38 | |
HBV genotype (A/B/C/D) | 0/14/15/1 | NA | |
HCV genotype (1b/2a/2b) | NA | 34/4/0 |
Metabolite | Coefficient | 95%CI | Odds ratio | 95%CI | P value | ||
(Intercept) | -8.01 | -14.0 | -4.14 | 1.00 × 10-3 | |||
Met | 0.0521 | 0.018 | 0.0979 | 1.05 | 1.02 | 1.10 | 8.60 × 10-3 |
γ-Glu-Gly-Gly | -17.6 | -35.7 | -5.31 | 2.23 × 10-8 | 3.18 × 10-16 | 4.93 × 10-3 | 1.97 × 10-2 |
Glu | 0.0255 | 0.0135 | 0.0454 | 1.03 | 1.01 | 1.05 | 1.30 × 10-3 |
Amino acid | γ-glutamyl peptides | Spearman R | 95%CI | P value(two-tailed) |
Ile | γ-Glu-Ile | 0.4584 | 0.2401-0.6325 | < 0.0001 |
Ala | γ-Glu-Ala | 0.04022 | -0.4898 | 0.7447 |
Ser | γ-Glu-Ser | 0.2117 | -0.4698 | 0.0831 |
Val | γ-Glu-Val | 0.4565 | 0.2379-0.6311 | < 0.0001 |
Thr | γ-Glu-Thr | 0.3909 | 0.1610-0.5805 | 0.001 |
Leu | γ-Glu-Leu | 0.4898 | 0.2779-0.6562 | < 0.0001 |
Asn | γ-Glu-Asn | 0.4012 | 0.1729-0.5885 | 0.0007 |
Lys | γ-Glu-Lys | 0.2909 | 0.04915-0.5004 | 0.0161 |
Gln | γ-Glu-Gln | 0.6387 | 0.4665-0.7642 | < 0.0001 |
Glu | γ-Glu-Glu | 0.8268 | 0.7294-0.8913 | < 0.0001 |
His | γ-Glu-His | 0.2982 | 0.05714-0.5064 | 0.0135 |
Phe | γ-Glu-Phe | 0.4886 | 0.2765-0.6554 | < 0.0001 |
Arg | γ-Glu-Arg | 0.4258 | 0.2016-0.6076 | 0.0003 |
Tyr | γ-Glu-Tyr | 0.6937 | 0.5404-0.8024 | < 0.0001 |
Asp | γ-Glu-Asp | 0.5566 | 0.3606-0.7056 | < 0.0001 |
Met | γ-Glu-Met | 0.5418 | 0.3420-0.6947 | < 0.0001 |
Trp | γ-Glu-Trp | 0.3433 | 0.1070-0.5428 | 0.0042 |
Gly | γ-Glu-Gly | 0.05704 | -0.489 | 0.6441 |
Gly | γ-Glu-Gly-Gly | 0.006012 | -0.4905 | 0.9612 |
- Citation: Saito T, Sugimoto M, Okumoto K, Haga H, Katsumi T, Mizuno K, Nishina T, Sato S, Igarashi K, Maki H, Tomita M, Ueno Y, Soga T. Serum metabolome profiles characterized by patients with hepatocellular carcinoma associated with hepatitis B and C. World J Gastroenterol 2016; 22(27): 6224-6234
- URL: https://www.wjgnet.com/1007-9327/full/v22/i27/6224.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i27.6224